Market-based licensing for HPV vaccines in developing countries

Health Affairs
Kevin Outterson, Aaron S Kesselheim

Abstract

Human papillomavirus (HPV) vaccines hold great promise for preventing cervical cancer, but 93 percent of mortality worldwide occurs in low- and middle-income countries, where high vaccine costs can restrict dissemination. Current models for promoting international access to health care innovations include differential pricing, advance market commitments, and voluntary and compulsory licensing. Some of these mechanisms have been effective, but much room for improvement remains. We discuss the usefulness of a new type of license that uses market forces to lower prices through generic competition in low- and middle-income countries while ensuring that pharmaceutical companies are appropriately reimbursed for their research and development.

References

Oct 3, 2003·Lancet·Carl B Feldbaum
Apr 22, 2004·Journal of the National Cancer Institute·Sue J GoldieEduardo Franco
Aug 21, 2004·Health Affairs·Peter Stein, Ernst Valery
May 12, 2005·Health Affairs·Ernst R Berndt, John A Hurvitz
Nov 18, 2005·The New England Journal of Medicine·Sue J GoldieUNKNOWN Alliance for Cervical Cancer Prevention Cost Working Group
Jan 26, 2006·JAMA : the Journal of the American Medical Association·Aaron S Kesselheim, Jerry Avorn
Mar 2, 2006·Journal of the National Cancer Institute·Xavier CastellsaguéUNKNOWN International Agency for Research on Cancer Multicenter Cervical Cancer Study Group
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Farin KamangarWilliam F Anderson
Jul 15, 2006·BMJ : British Medical Journal·Janice Tanne
Aug 3, 2006·Journal of the National Cancer Institute·Renee Twombly
Nov 24, 2006·Nature·Erika Check
Feb 3, 2007·Globalization and Health·Samantha ChaifetzYochai Benkler
Feb 9, 2007·The New England Journal of Medicine·Robert Steinbrook
May 15, 2007·The New England Journal of Medicine·R Alta Charo
May 15, 2007·The New England Journal of Medicine·Jan M Agosti, Sue J Goldie
May 15, 2007·The New England Journal of Medicine·Suzanne M GarlandUNKNOWN Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators
Jul 4, 2007·Vaccine·Sue J GoldieEduardo L Franco

❮ Previous
Next ❯

Citations

Jul 14, 2010·Nature Biotechnology·Swathi PadmanabhanSubhashini Chandrasekharan
Nov 7, 2008·The New England Journal of Medicine·Aaron S Kesselheim
Apr 9, 2008·BMJ : British Medical Journal·Dave A Chokshi, Aaron S Kesselheim
Apr 9, 2011·Lancet·Robert BeagleholeUNKNOWN NCD Alliance
Jun 6, 2009·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Jerome H Reichman
Jun 11, 2008·Haemophilia : the Official Journal of the World Federation of Hemophilia·J Kimmelman
Jan 23, 2014·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Aakash Kaushik ShahAaron S Kesselheim
Feb 11, 2012·Journal of Medical Microbiology·Petra Oyston, Karen Robinson
Aug 27, 2009·Health Affairs·Tahir AminAaron S Kesselheim
Apr 6, 2011·European Journal of Pediatrics·Irine-Ikbale SakouMaria N Tsolia
Oct 20, 2017·International Journal of Health Economics and Management·Mario Songane

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved